The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with prolonged exposure therapy for posttraumatic stress disorder.

Subjects

Subjects :

Humans
N-Methyl-3,4-methylenedioxyamphetamine pharmacology
Implosive Therapy
Stress Disorders, Post-Traumatic drug therapy
Hallucinogens therapeutic use

Details

Language :

English

ISSN :

1740-634X

Volume :

48

Issue :

1

Database :

MEDLINE

Journal :

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Publication Type :

Periodical

Accession number :

35859012

Full Text :

https://doi.org/10.1038/s41386-022-01381-7